litlas
Log inCreate account

Andrew D. Luster

Active 1985–2025

Also published as
Andrew D Luster
220
Papers
61,645
Citations
132
h-index
218
i10-index

Citations

Citations per year for Andrew D. Luster1986: 8 citations1987: 20 citations1988: 45 citations1989: 62 citations1990: 56 citations1991: 39 citations1992: 38 citations1993: 45 citations1994: 41 citations1995: 47 citations1996: 83 citations1997: 122 citations1998: 252 citations1999: 461 citations2000: 409 citations2001: 476 citations2002: 482 citations2003: 520 citations2004: 568 citations2005: 603 citations2006: 644 citations2007: 655 citations2008: 719 citations2009: 629 citations2010: 668 citations2011: 730 citations2012: 639 citations2013: 640 citations2014: 658 citations2015: 639 citations2016: 605 citations2017: 562 citations2018: 576 citations2019: 1,738 citations2020: 1,900 citations2021: 1,976 citations2022: 1,535 citations2023: 1,178 citations2024: 1,656 citations2025: 885 citations2026: 24 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 8,414 citing papers, 32% of this breakdownChina: 2,671 citing papers, 10.2% of this breakdownGermany: 1,709 citing papers, 6.5% of this breakdownUnited Kingdom: 1,577 citing papers, 6% of this breakdownJapan: 1,114 citing papers, 4.2% of this breakdownFrance: 960 citing papers, 3.7% of this breakdownItaly: 937 citing papers, 3.6% of this breakdownCanada: 874 citing papers, 3.3% of this breakdownSwitzerland: 677 citing papers, 2.6% of this breakdownAustralia: 672 citing papers, 2.6% of this breakdownNetherlands: 668 citing papers, 2.5% of this breakdownSpain: 434 citing papers, 1.6% of this breakdown
0%32%Other 21.2%

Institutions

Fields

  • Medicine47.3%
  • Immunology and Microbiology27.6%
  • Biochemistry, Genetics and Molecular Biology15.4%
  • Neuroscience5.6%
  • Engineering1%
  • Agricultural and Biological Sciences0.7%
  • Other2.4%

Topics

  • Immune Cell Function and Interaction5.3%
  • Immunotherapy and Immune Responses4.6%
  • Chemokine receptors and signaling4.6%
  • T-cell and B-cell Immunology4.2%
  • Immune Response and Inflammation3.5%
  • Immune cells in cancer3.1%
  • Other74.7%

Coauthors

All papers

Open in search
  1. Chemokines and the immune response to cancer

    Authors: Aleksandra J. Ozga, Melvyn T. Chow, Andrew D. Luster - Immunity 2021 cited by 808

  2. Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity

    Authors: Jason W. Griffith, Caroline L. Sokol, Andrew D. Luster - Annual Review of Immunology 2014 cited by 2,087

  3. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy

    Authors: Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis, Dennie T. Frederick, Jennifer A. Lo, David E. Fisher, Gordon J. Freeman, Genevieve M. Boland, Andrew D. Luster - Immunity 2019 cited by 710

  4. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment

    Authors: Mauro Di Pilato, Raphael Kfuri‐Rubens, Jasper N. Pruessmann, Aleksandra J. Ozga, Marius Messemaker, Bruno L. Cadilha, Ramya Sivakumar, Chiara Cianciaruso, Ross D. Warner, Francesco Marangoni, Esteban Carrizosa, Stefanie Lesch, James M. Billingsley, Daniel W. Pérez-Ramos, Fidel Zavala, Esther Rheinbay, Andrew D. Luster, Michael Y. Gerner, Sebastian Kobold, Mikaël J. Pittet, Thorsten R. Mempel - Cell 2021 cited by 485

  5. The Chemokine System in Innate Immunity

    Authors: Caroline L. Sokol, Andrew D. Luster - Cold Spring Harbor Perspectives in Biology 2015 cited by 888

  6. CXCR3 in T cell function

    Authors: Joanna R. Groom, Andrew D. Luster - Experimental Cell Research 2011 cited by 1,008

  7. A human model of asthma exacerbation reveals transcriptional programs and cell circuits specific to allergic asthma

    Authors: Jehan Alladina, Neal P. Smith, Tristan Kooistra, Kamil Slowikowski, Isabela Kernin, Jacques Deguine, Henry L. Keen, Kasidet Manakongtreecheep, Jessica Tantivit, Rod A. Rahimi, Susan L. Sheng, Nhan D. Nguyen, Alexis M. Haring, Francesca Giacona, Lida P. Hariri, Ramnik J. Xavier, Andrew D. Luster, Alexandra–Chloé Villani, Josalyn L. Cho, Benjamin D. Medoff - Science Immunology 2023 cited by 137

  8. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

    Authors: Andrew M. Tager, Peter LaCamera, Barry S. Shea, Gabriele Campanella, Moisés Selman, Zhenwen Zhao, Vasiliy V. Polosukhin, John Wain, Banu A. Karimi-Shah, Nancy D. Kim, William K. Hart, Annie Pardo, Timothy S. Blackwell, Yan Xu, Jerold Chun, Andrew D. Luster - Nature Medicine 2007 cited by 818

  9. Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity

    Authors: Lauren B. Rodda, Erick Lu, Mariko L. Bennett, Caroline L. Sokol, Xiaoming Wang, Sanjiv A. Luther, Ben A. Barres, Andrew D. Luster, Chun Ye, Jason G. Cyster - Immunity 2018 cited by 444

  10. CXCR3 ligands: redundant, collaborative and antagonistic functions

    Authors: Joanna R. Groom, Andrew D. Luster - Immunology and Cell Biology 2011 cited by 1,005

  11. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

    Authors: Françoise Bachelerie, Adit Ben‐Baruch, Amanda M. Burkhardt, Christophe Combadière, Joshua Μ. Farber, Gerard J. Graham, Richard Horuk, Alexander H. Sparre‐Ulrich, Massimo Locati, Andrew D. Luster, Alberto Mantovani, Kouji Matsushima, Philip M. Murphy, Robert J. B. Nibbs, Hisayuki Nomiyama, Christopher Power, Amanda E. I. Proudfoot, Mette M. Rosenkilde, Antal Rot, Silvano Sozzani, Marcus Thelen, Osamu Yoshie, Albert Zlotnik - Pharmacological Reviews 2013 cited by 849

  12. IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking

    Authors: Jennifer Dufour, Michelle Dziejman, Michael T. Liu, Josephine H. Leung, Thomas E. Lane, Andrew D. Luster - The Journal of Immunology 2002 cited by 1,073

  13. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

    Authors: Maryann Mikucki, Daniel T. Fisher, Junko Matsuzaki, Joseph J. Skitzki, Nicole Gaulin, Jason B. Muhitch, Amy Ku, John G. Frelinger, Kunle Odunsi, Thomas F. Gajewski, Andrew D. Luster, Sharon S. Evans - Nature Communications 2015 cited by 497

  14. CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo

    Authors: Mehdi Rashighi, Priti Agarwal, Jillian M. Richmond, Tajie H. Harris, Karen Dresser, Mingwan Su, Youwen Zhou, April Deng, Christopher A. Hunter, Andrew D. Luster, John E. Harris - Science Translational Medicine 2014 cited by 489

  15. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

    Authors: Joseph El Khoury, Michelle Toft, Suzanne E. Hickman, Terry K. Means, Kinya Terada, Changiz Geula, Andrew D. Luster - Nature Medicine 2007 cited by 901

  16. Immune cell migration in inflammation: present and future therapeutic targets

    Authors: Andrew D. Luster, R. Alon, Ulrich H. von Andrian - Nature Immunology 2005 cited by 1,348

  17. CD36 Mediates the Innate Host Response to β-Amyloid

    Authors: Joseph El Khoury, Kathryn J. Moore, Terry K. Means, Josephine H. Leung, Kinya Terada, Michelle Toft, Mason W. Freeman, Andrew D. Luster - The Journal of Experimental Medicine 2003 cited by 480

  18. Migratory DCs activate TGF-β to precondition naïve CD8 + T cells for tissue-resident memory fate

    Authors: V. Mani, Shannon K. Bromley, Tarmo Äijö, Rut Mora‐Buch, Esteban Carrizosa, Ross D. Warner, Moustafa Hamze, Debattama R. Sen, Alexandra Y. Chasse, Alina Lorant, Jason W. Griffith, Rod A. Rahimi, Craig P. McEntee, Kate L. Jeffrey, Francesco Marangoni, Mark A. Travis, Adam Lacy‐Hulbert, Andrew D. Luster, Thorsten R. Mempel - Science 2019 cited by 210

  19. Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease

    Authors: Jillian M. Richmond, Dinesh S. Bangari, Kingsley I. Essien, Sharif Currimbhoy, Joanna R. Groom, Amit G. Pandya, Michele Youd, Andrew D. Luster, John E. Harris - Journal of Investigative Dermatology 2016 cited by 217

  20. Astrocyte- and Neuron-Derived CXCL1 Drives Neutrophil Transmigration and Blood-Brain Barrier Permeability in Viral Encephalitis

    Authors: Benedict Michael, Laura Bricio-Moreno, Elizabeth W. Sorensen, Yoshishige Miyabe, Jeffrey Lian, Tom Solomon, Evelyn A. Kurt‐Jones, Andrew D. Luster - Cell Reports 2020 cited by 156

  21. Neutrophils cascading their way to inflammation

    Authors: Christian D. Sadik, Nancy D. Kim, Andrew D. Luster - Trends in Immunology 2011 cited by 566

  22. Chemokines in Cancer

    Authors: Melvyn T. Chow, Andrew D. Luster - Cancer Immunology Research 2014 cited by 485

  23. CXCR3 Chemokine Receptor-Ligand Interactions in the Lymph Node Optimize CD4+ T Helper 1 Cell Differentiation

    Authors: Joanna R. Groom, Jillian M. Richmond, Thomas T. Murooka, Elizabeth W. Sorensen, Jung Hwan Sung, Katherine Bankert, Ulrich H. von Andrian, James Moon, Thorsten R. Mempel, Andrew D. Luster - Immunity 2012 cited by 429

  24. Targeting CXCR4-dependent immunosuppressive Ly6C low monocytes improves antiangiogenic therapy in colorectal cancer

    Authors: Keehoon Jung, Takahiro Heishi, João Incio, Yuhui Huang, Elizabeth Beech, Matthias Pinter, William W. Ho, Kosuke Kawaguchi, Nuh N. Rahbari, Euiheon Chung, Jun Ki Kim, Jeffrey W. Clark, Christopher G. Willett, Seok Hyun Yun, Andrew D. Luster, Timothy P. Padera, Rakesh K. Jain, Dai Fukumura - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 134